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If medical journals and public health
advocates are concerned with corporate
conflicts of interest, inappropriate market-
ing to children, impotent self-regulation,
and general flouting of the rules, why are
we ignoring the alcohol industry?
The crisis of confidence that surrounds
the behavior and practices of Big Tobacco
and Big Pharma [1,2]—bias in funded
research, unsupported claims of benefit,
and inappropriate promotion and market-
ing, among others—should be enough to
provoke in us all a high degree of
skepticism with any industry involvement
in health research and policy. But the
evidence and critical voices highlighting
the practices of the alcohol industry—a
massive and growing US$150 billion
global business—have not yet received
adequate prominence in medical journals.
Indeed, attention to and scientific research
on the alcohol industry have not kept pace
with the industry’s ability to grow and
evolve its markets and influence in the
health arena [3].
So why are we soft on alcohol? One
reason might be the enduring perception
that drinking is normal, fun, and healthy,
and that the damage caused by alcohol
affects only a small group of people who
can’t handle their booze [4]. But the
independent statistics defy this rosy view:
the Global Burden of Disease study places
alcohol-related morbidity second only to
tobacco in the developed world [5],
teenage drinking problems have been
shown to have long term effects on
individuals and communities [6], and a
recent European-wide study [7] found that
10% of cancers in men and 3% in women
were linked to alcohol consumption.
While the statistics on alcohol’s harms
are troubling enough, it’s the practices of
the alcohol industry, including its influ-
ence on government policy, health re-
search, and public perceptions, that really
begs for more of our attention. Several
recent examples signal a need for more
scrutiny.
In the UK, there have been scathing
allegations [8] that the current govern-
ment is too close to the drinks industry,
including its recent invitations allowing
industry representatives to influence public
health policy, which led to a withdrawal of
support for a key alcohol policy by major
organizations including the British Medi-
cal Association, Royal College of Physi-
cians, and several alcohol control charities
[9,10]. Similar interference in government
policy by the alcohol industry, in which
scientific evidence was ignored and indus-
try interests inserted into national alcohol
policies, was recently documented for sub-
Saharan Africa [11].
In the US, a recent review [12] of
alcohol industry–funded health research
found very little that could contribute to
reducing alcohol-related illness. But, wor-
ryingly, Barbor did find a lot of potential
for the alcohol industry’s involvement in
science—whether supporting individual
scientists, research councils, conferences,
or journals—to result in messages that
obscure public perceptions of the true
benefits and harms of alcohol and to
support the industry’s PR agenda, while
also supplying industry with the opportu-
nity to ‘‘demonstrate corporate responsi-
bility in its attempts to avoid taxation and
regulation’’ [12].
Recent analyses have also shown the
alcohol industry’s savvy in deflecting
government controls aimed at protecting
the public—for example, the industry’s
marketing innovations in the use of social
media, sports sponsorships, and product
placements in film are said to be designed
to evade policies restricting broadcast and
print ads [13]. And, Hastings and col-
leagues [14] last month demonstrated how
UK alcohol companies and their PR firms
continue to market to youth, encourage
drunkenness, and link drinking to socia-
bility and social success despite explicit
self-regulatory codes prohibiting this type
of advertising.
None of this would surprise the Marin
Institute (http://www.marininstitute.org/
site/), the California-based alcohol indus-
try watchdog, whose work has document-
ed a laundry list of misdeeds by ‘‘Big
Alcohol’’: promoting the health benefits of
alcohol while downplaying harms; deflect-
ing attention away from scientific data that
contradict industry exaggerations of ben-
efit; tactically targeting specific markets of
underage youth, people of color, and poor
people; and engaging in philanthropy to
promote brand loyalty.
If this questionable behavior is reminis-
cent of the strategies developed by the
pharmaceutical, tobacco, and other indus-
tries to further their agendas, it should be a
wake-up call to us all. And, as with the
pharmaceutical and tobacco industries
(whose marketing budgets far exceed the
public funding of independent research),
efforts to counter such dubious tactics face a
formidable and well-resourced industrial
opponent. However, experience with other
industries, especially through tobacco con-
trolefforts,canalsoteachus alot abouthow
to critically examine and resist the alcohol
industry’s behavior and practices. Galva-
nizing the support of non-governmental
organizations and governments, along with
a solid base of independent evidence, led to
the ratification of the Framework Conven-
tion on Tobacco Control, and there have
been proposals for a similar Framework
Convention on Alcohol Control [15,16]—a
move that would recognize the need for
collective global action and could counter
the alcohol industry’s age-old attempts to
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drinking and deflect attention away from
their own role in promotion.
Whether the solutions are stricter regu-
lation over advertising and promotion,
banning sports sponsorships, setting min-
imum pricing, restricting access, introduc-
ing mandatory safety labeling, or holding
the industry to account for the harms
associated with their products, there is a
need now to target more attention to and
research on the alcohol industry that can
support and fuel legislative, regulatory,
and community action to protect the
public health. Let’s be straight up about
the alcohol industry.
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